Status:

COMPLETED

Colonic Propionate, Appetite, and Weight Loss

Lead Sponsor:

Imperial College London

Collaborating Sponsors:

University of Glasgow

Conditions:

Healthy Obesity, Metabolically

Appetite Regulation

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

The current protocol aims to investigate the impact of the propionate ester in conjugation with restricted diet on appetite and weight loss.

Detailed Description

DIET AND OBESITY: Obesity has reached epidemic proportions worldwide. In the United Kingdom, 58% of adult women and 65% of adult men are either overweight or obese (Health and Social Care Information...

Eligibility Criteria

Inclusion

  • overweight or obese ((BMI) of 25-35 kg/m2)
  • healthy
  • aged between 18 and 65 years

Exclusion

  • Weight change of ≥ 3kg in the preceding 2 months
  • Undergone any weight loss surgery or gastric procedures to promote weight loss
  • Current smokers
  • Substance abuse
  • Excess alcohol intake
  • Pregnancy
  • Diabetes
  • Cardiovascular disease
  • Cancer
  • Gastrointestinal disease e.g. inflammatory bowel disease or irritable bowel syndrome
  • Kidney disease
  • Liver disease
  • Pancreatitis
  • Use of medications likely to interfere with energy metabolism, appetite regulation and hormonal balance, including: anti-inflammatory drugs or steroids, antibiotics, androgens, phenytoin, erythromycin or thyroid hormones.
  • Any participants with the above conditions would already have an altered pattern of hormones and inflammatory molecules because of their disease process and would therefore give us confounding or misleading results.

Key Trial Info

Start Date :

March 29 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 11 2017

Estimated Enrollment :

12 Patients enrolled

Trial Details

Trial ID

NCT03322514

Start Date

March 29 2017

End Date

November 11 2017

Last Update

November 20 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

NIHR/Wellcome Trust Imperial Clinicial Research Facility

London, United Kingdom, W12 0NN